CAMBRIDGE, Mass.-- Alnylam Pharmaceuticals Inc. said Monday it took a smaller loss in the first quarter as its expenses decreased. Alnylam lost $9 million, or 15 cents per share, in the latest quarter. A year ago the company took a loss of $11.4 million, or 25 cents per share.
"Drug stocks can rally in any environment," Cramer said, highlighting three companies in particular.
The "Mad Money" host comments on viewers' favorite stocks!